Dew, Since GTCB now has the broad US patent for the production of any therapeutic protein in the milk of any transgenic animal (through 2021), will potential competitors like Pharming and Avigenics first have to obtain a license from GTCB prior to commercializing any of their transgenic products? Do you know if GTCB has a similar patent in Europe, or one pending? Thanks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.